Peptide mimics of a tumor antigen induce functional cytotoxic T cells

被引:47
作者
Apostolopoulos, V
Lofthouse, SA
Popovski, V
Chelvanayagam, G
Sandrin, MS
McKenzie, IFC
机构
[1] Austin Res Inst, Heidelberg, Vic 3084, Australia
[2] Australian Natl Univ, John Curtin Sch Med Res, Dept Human Genet, Canberra, ACT 2601, Australia
关键词
applied immunology; tumor therapy; MUC1;
D O I
10.1038/nbt0398-276
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The ability to mimic peptide/peptide and/or peptide/carbohydrate structures may be important in generating cross-reactive antibodies for autoimmune and other diseases. We show that the peptide sequence DAHWESWL can mimic the conformation of the unrelated MUC1 peptide SAPDTRPAP(G). Mice immunized with mannan-MUC1-peptides make cytotoxic T lymphocytes (CTLs) and are protected from MUC1(+) tumors. We show that the same specific anti-MUC1 responses can be produced by immunizing with the DAHWESWL peptide; furthermore, specific tumor protection is obtained in a manner similar to that with MUC1 immunization. The DAHWESWL peptide immunization leads to CTLs that recognize H2D(d) and HaL(d-) but not H2(b) or human leukocyte antigens-group A (HLA-A)*0201 presented MUC1 peptides. However, mutation of the DAHWESWL peptide to a more HLA-A*0201-compatible structure with appropriate anchors (DLHWASWV), leads to the production of CTLs in HLA-A*0201 mice.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 33 条
[1]  
APOSTOLOPOULOS V, 1994, CANCER RES, V54, P5186
[2]   Breast cancer immunotherapy: Current status and future prospects [J].
Apostolopoulos, V ;
McKenzie, IFC ;
Pietersz, GA .
IMMUNOLOGY AND CELL BIOLOGY, 1996, 74 (05) :457-464
[3]   PRODUCTION OF ANTI-BREAST CANCER MONOCLONAL-ANTIBODIES USING A GLUTATHIONE-S-TRANSFERASE-MUC1 BACTERIAL FUSION PROTEIN [J].
APOSTOLOPOULOS, V ;
XING, PX ;
TRAPANI, JA ;
MCKENZIE, IFC .
BRITISH JOURNAL OF CANCER, 1993, 67 (04) :713-720
[4]   Cell-mediated immune responses to MUC1 fusion protein coupled to mannan [J].
Apostolopoulos, V ;
Pietersz, GA ;
McKenzie, IFC .
VACCINE, 1996, 14 (09) :930-938
[5]   OXIDATIVE REDUCTIVE CONJUGATION OF MANNAN TO ANTIGEN SELECTS FOR T-1 OR T-2 IMMUNE-RESPONSES [J].
APOSTOLOPOULOS, V ;
PIETERSZ, GA ;
LOVELAND, BE ;
SANDRIN, MS ;
MCKENZIE, IFC .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (22) :10128-10132
[6]  
Apostolopoulos V, 1997, J IMMUNOL, V159, P5211
[7]   MUC1 peptide epitopes associated with five different H-2 class I molecules [J].
Apostolopoulos, V ;
Haurum, JS ;
McKenzie, IFC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (10) :2579-2587
[8]   SPECIFIC, MAJOR HISTOCOMPATIBILITY COMPLEX - UNRESTRICTED RECOGNITION OF TUMOR-ASSOCIATED MUCINS BY HUMAN CYTO-TOXIC T-CELLS [J].
BARND, DL ;
LAN, MS ;
METZGAR, RS ;
FINN, OJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (18) :7159-7163
[9]   Use of combinatorial peptide libraries to construct functional mimics of tumor epitopes recognized by MHC class I-restricted cytolytic T lymphocytes [J].
Blake, J ;
Johnston, JV ;
Hellstrom, KE ;
Marquardt, H ;
Chen, LP .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (01) :121-130
[10]   A SHORT SEQUENCE, WITHIN THE AMINO-ACID TANDEM REPEAT OF A CANCER-ASSOCIATED MUCIN, CONTAINS IMMUNODOMINANT EPITOPES [J].
BURCHELL, J ;
TAYLORPAPADIMITRIOU, J ;
BOSHELL, M ;
GENDLER, S ;
DUHIG, T .
INTERNATIONAL JOURNAL OF CANCER, 1989, 44 (04) :691-696